calculate-loan

01 Loan payments

JNJ Debt to Equity Ratio: Current Data & Trends

Calculator No. 01-24098 · Updated · Formula and assumptions shown below

Debt-to-equity ratio 0.375
Debt as % of equity
37.5 %
= Total debt ÷ shareholders' equity × 100
Total debt
$30,000
Input
Shareholders' equity
$80,000
Input
You enter
Total debt ($), Shareholders' equity ($)
You get
Debt-to-equity ratio, Debt as % of equity (%)
Rounding
2 dp · 1 dp

Estimate for education, not financial advice. The result follows from the numbers you enter and the formula shown. It is not a quote or an offer, and it does not include fees, taxes or insurance unless the calculator asks for them. Ask your lender for the exact figures.

Johnson & Johnson’s (JNJ) debt-to-equity ratio was approximately 0.37 as of the company’s most recent quarterly filing (Q3 2024). This means the company uses about $0.37 of debt for every $1 of shareholders’ equity, a relatively conservative level for a large healthcare conglomerate. Below, we break down what this figure means, how it compares historically, and what investors should consider when interpreting it.

Formula

The debt-to-equity ratio is calculated as:

Debt-to-Equity = Total Liabilities / Shareholders’ Equity

or more specifically, using interest-bearing debt:

Debt-to-Equity = (Short-term Debt + Long-term Debt) / Total Shareholders’ Equity

Where:

  • Total Debt includes all interest-bearing obligations, such as bonds, loans, and finance leases.
  • Shareholders’ Equity is total assets minus total liabilities, representing the book value of the company’s net worth.

Some analysts prefer to use only long-term debt, while others include all liabilities. The most common approach uses total interest-bearing debt, which is what our calculator above does.

Worked Example

Using the default values from the calculator (Total Debt = $30,000, Shareholders’ Equity = $80,000):

  1. Divide total debt by equity: $30,000 / $80,000 = 0.375
  2. Round to two decimal places: 0.38

The calculator shows 0.38, matching this step-by-step calculation. This means the company has $0.38 of debt for every $1 of equity.

Assumptions

  • Debt includes both short-term and long-term interest-bearing obligations, but excludes non-interest-bearing liabilities like accounts payable.
  • Equity is the book value, not market value.
  • The ratio is a point-in-time measure and can fluctuate with quarterly earnings, share buybacks, or debt issuance.
  • This calculator is for educational purposes only and does not reflect JNJ’s actual figures unless you input them.

JNJ’s Debt-to-Equity Over Time

Johnson & Johnson’s debt-to-equity ratio has seen notable shifts over the past decade. In 2015, the ratio was around 0.40. It spiked to 0.60 in 2018 following the acquisition of Actelion, which added debt. After the company’s consumer health spin-off (Kenvue) in 2023, JNJ’s debt-to-equity dropped significantly because the spin-off transferred a portion of debt to the new entity. The current level of ~0.37 is below the 5-year average of ~0.50, indicating a deleveraging trend.

How to Interpret the Ratio

A lower debt-to-equity ratio generally suggests a company is less reliant on borrowing. For JNJ, a ratio under 0.5 is typical for a large-cap pharmaceutical company with stable cash flows. Here are some key points:

  • Below 0.5: Conservative leverage; the company can easily cover interest payments from operating income.
  • 0.5 to 1.0: Moderate leverage; common in capital-intensive industries.
  • Above 2.0: High leverage; may indicate financial stress or aggressive growth financing.

However, the ratio must be compared to industry peers. Other pharma giants like Pfizer and Merck often have ratios between 0.5 and 0.8, so JNJ is on the lower end.

Common Misconceptions

One common mistake is using total liabilities instead of interest-bearing debt. If you include accounts payable and accrued expenses, the ratio would be much higher (JNJ’s total liabilities/equity is around 1.5), but that’s not the standard measure. Another error is using market value of equity instead of book value—this can distort the ratio, especially when stock prices are volatile.

Investors also confuse debt-to-equity with the debt-to-assets ratio. The former compares debt to shareholder claims, while the latter compares debt to total assets. They measure different things.

Why JNJ’s Ratio Matters

JNJ’s debt level affects its credit rating, interest costs, and ability to return cash to shareholders. A lower ratio gives the company financial flexibility to weather downturns or make acquisitions. For dividend investors, a stable or declining debt-to-equity ratio is reassuring because it suggests the dividend is well-covered by earnings and not funded by borrowing.

However, a very low ratio could also mean the company is under-leveraging and not optimizing its capital structure. Since interest is tax-deductible, some debt can lower the cost of capital. JNJ’s management has historically balanced this well, maintaining a strong balance sheet while still returning value to shareholders.

Frequently Asked Questions

What is JNJ’s current debt-to-equity ratio?

As of Q3 2024, JNJ’s debt-to-equity ratio is approximately 0.37, based on total debt of about $28 billion and shareholders’ equity of about $76 billion. The exact figure may vary slightly depending on the source and whether you include operating lease liabilities.

How does JNJ’s ratio compare to competitors?

JNJ’s ratio is lower than many peers. For example, Pfizer has a ratio around 0.7, Merck around 0.6, and AbbVie around 1.0. JNJ’s conservative balance sheet is a competitive advantage in the pharmaceutical industry.

Why did JNJ’s debt-to-equity ratio drop after the Kenvue spin-off?

In 2023, JNJ spun off its consumer health division into Kenvue, transferring a portion of its debt to the new company. This reduced JNJ’s total debt by roughly $10 billion, while equity remained relatively stable, lowering the ratio from about 0.5 to 0.37.

Is a lower debt-to-equity ratio always better?

Not necessarily. While lower debt reduces financial risk, it can also mean a company is not taking advantage of cheap financing to grow. For JNJ, the moderate ratio is appropriate given its stable cash flows and need for R&D investment.

Does the ratio include pension liabilities?

No, pension obligations are typically not included in the standard debt-to-equity calculation. They are disclosed separately in the footnotes. If included, JNJ’s ratio would be slightly higher, but most analysts exclude them for consistency.

Where can I find JNJ’s debt and equity figures?

These figures are in JNJ’s quarterly and annual reports (Form 10-Q and 10-K) filed with the SEC. Look at the balance sheet: total debt is the sum of short-term and long-term debt, and equity is the total shareholders’ equity line.

Remember, this ratio is a snapshot and can change quarterly. Always use the latest filing for current analysis.

This calculation is an estimate for educational purposes; the company’s official filings provide the exact figures.

Related

Formula used
in p | Total debt | $ | 30000 | 0 | 100000000
in eq | Shareholders' equity | $ | 80000 | 1 | 100000000
out d_e | Debt-to-equity ratio | - | p / eq | 2
out debt_pct | Debt as % of equity | % | p / eq * 100 | 1

Each line is one input (in, sel, list) or one result (out: label, unit, formula, decimals). How the calculators work

Method: the standard loan formula for this calculation, fixed rate and monthly compounding unless stated, rounded as each result states. Not financial advice; no lender, rate or product is recommended. See formulas and assumptions, the disclaimer or report an error.

More in this section

The whole Loan payments section →